When Your Audit Firm No Longer Fits: What Life Sciences Companies Should Know
High costs, poor communication, and a lack of urgency during critical transition periods – these are signs that staying with your current assurance firm costs more than it delivers. For life sciences companies operating in an already complex financial environment, that misalignment creates disruption that compounds quickly.
Staying with an ineffective or overly expensive auditor can slow progress by delaying decision-making, reducing confidence in financial reporting, and placing additional strain on internal teams during critical phases of growth or transformation.
This article explores the reasons life sciences companies are reevaluating their current audit relationships and the factors that influence a potential transition.
Key Takeaways
- Life sciences companies often reevaluate their auditor when costs, responsiveness, and service quality no longer align with their needs.
- The wrong audit partner can lead to financial reporting inefficiencies, delayed filings, and added strain on internal teams.
- Assurance requirements can change rapidly during financing, restructuring, M&A activity, and IPO preparation.
- A right-sized, industry-focused audit team can provide greater flexibility, communication, and value.
- The best audit relationships evolve alongside a company’s growth, goals, and operational complexity.
Why Life Sciences Companies Reevaluate Their Audit Firm
Every life sciences company has distinct operational needs. These needs drive decision-making – whether that means reducing or realigning spending, navigating financings, mergers, acquisitions, or other restructuring initiatives, or meeting financial reporting objectives and deadlines. Above all, these companies require providers who deliver the right level of communication and attention to keep priorities on track.
As a result, life sciences companies often reevaluate their audit firm when the size, responsiveness, and cost of the engagement team no longer align with their business objectives or the value they receive from the audit relationship.
Mid-sized assurance firms with deep, industry-specific expertise deliver right-sized engagement teams – bringing the flexibility, communication, and focus that larger providers often lack, at cost-effective rates that are supported by the effort of these engagement teams.
The Cost of Staying With the Wrong Auditor
Staying with the wrong auditor can subject your company to certain risks pertaining to its financial reporting requirements. The consequences escalate quickly:
- Delayed filings: Poor communication slows required submissions, frustrating both internal and external teams.
- Regulatory, investor and lender penalties: Late filings trigger direct consequences with the regulators, investors, and lenders that matter most.
- Strained finance teams: Breakdowns in communication create inefficiencies that put unnecessary pressure on your team.
The right auditor keeps these risks off the table.
As your company evolves, so will your audit needs. For life sciences companies, the pace of change can be significant as organizations move between discovery, research and development, and commercialization stages – often on accelerated timelines.
Key events that can rapidly change audit requirements include:
- Mergers and acquisitions
- Financing rounds
- Restructurings
- IPO preparation
- Significant business and operational changes
Assurance Support That Evolves With Your Business
Wolf’s Life Sciences Assurance team understands the unique demands of the industry and provides responsive, unabating support as audit needs evolve. Our team is built to assess changing risks and requirements throughout each stage of growth. Rather than relying on a one-size-fits-all approach, we tailor audits risk assessments to your company’s specific circumstances. Dedicated team members bring specialized industry knowledge and continuity across engagements, delivering insights that align with your business goals.
As a client-centric assurance firm, we adapt our audit approach to meet your current needs and help avoid unnecessary audit costs. After all, resources spent on services that do not fit your stage of growth are resources that could be invested in moving your company forward.
Why Choose Wolf & Company’s Life Sciences & Assurance Practice?
Wolf’s life sciences assurance practice is one of the firm’s fastest-growing niches – expanding across both the clients we serve and our internal service teams.
The Life Sciences Service team brings extensive audit and assurance experience across the full company lifecycle: private entities, companies pursuing an IPO, and publicly traded organizations. Our engagement teams carry the technical accounting depth to align with your company’s operations, including accounting for revenue recognition, research and development expenses, share-based compensation, complex debt and equity transactions, and mergers and acquisitions.
Our audit teams are assembled to match both your company’s operations and audit requirements. Company management has direct, unrestricted access to engagement team members at every staffing level. A strong assurance relationship depends on flexibility, expertise, and commitment – qualities that define how Wolf’s Life Sciences Service team approaches every engagement, with your objectives as the primary focus.
Preparing for your first audit? Our Audit Readiness Checklist provides clarity on maintaining quality and efficiency throughout the IPO process.
Ready to get started? Connect with Wolf’s Life Sciences Service team today to discuss your assurance needs and how we can support your next stage of growth.
Emily Meyers
